An Open Label Single Arm Clinical Study To Evaluate The Effect Of Hingvadi Gutika In Udavarta Yonivyapada

SANE GURUJI AROGYA KENDRA1 个研究点分布在 1 个国家目标入组 30 人开始时间: 2024年2月15日最近更新: 2024年1月28日

试验速览

阶段: 2 期
状态: 尚未招募
发起方: SANE GURUJI AROGYA KENDRA
入组人数: 30
试验地点: 1
主要终点: The effect of Hingvadi Gutika 250 mg BD orally in Udavarta Yonivyapada

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

THIS IS AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFECT OF HINGVADI GUTIKA IN UDAVARTA YONIVYAPADA.

THE PRIMARY OBJECTIVE IS TO STUDY THE EFFECT OF HINGVADI GUTIKA IN UDAVARTA YONIVYAPADA FOR A DURATION OF 60 DAYS.

REGULAR ASSESSMENT OF SIGNS AND SYMPTOMS WILL BE DONE. OBSERVATION WILL BE DRAWN FROM THE OUTCOME OF PATIENT.

研究设计

研究类型: Interventional
分配方式: Not Applicable
盲法: Open Label

入排标准

年龄范围: 20.00 Year(s) 至 30.00 Year(s)（—）
性别: Female

入选标准

•Patient suffering from udavarta Yoni Vyapada
•Married or unmarried patient of age group 20 to30 yrs
•Patient having pain during Menstruation
•Patient having painful menses as compared to previous menses
•Patient ready for clinical trial.

排除标准

•Hypothyroidism, HIV, HbsAg, VDRL, prolactaemia, tuberculosis,utrine fibroid,complex ovarian cyst, dermoid cyst, tubo-ovarian mass, cervical polyp or growth.
•5 Patients suffering from uterine synechiae, endometriosis or malignancy.
•6 Pregnancy lactating and post natal female.

结局指标

主要结局

The effect of Hingvadi Gutika 250 mg BD orally in Udavarta Yonivyapada

时间窗: 18 months

次要结局

Literature study of Udavarta Yonivyapada.(Preparation of Hingvadi Gutika)

研究者

发起方

SANE GURUJI AROGYA KENDRA

申办方类型

Research institution and hospital

研究点 (1)

Loading locations...

相似试验

已完成

不适用

The Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension on Outpatients With Gastroesophageal Reflux Disease

NCT06889246Haiphong University of Medicine and Pharmacy27

已完成

不适用

To evaluate Efficacy and Safety study of Vatika Dandruff Guard Shampoo

CTRI/2022/03/040886Dabur International Limited36

招募中

1 期

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic CancerPancreatic Cancer

NCT06758544Guangdong Provincial People's Hospital18

尚未招募

1/2 期

AYURVEDIC MANAGEMENT OF VICHARCHIKA (ATOPIC DERMATITIS)i.e. Itching, Dishcharge, Burning Sensation, Dryness, Eruption, De pigmentation, Cracks of Skin.

CTRI/2023/10/058587POST GRADUATE INSTITUTE OF AYURVED JODHPUR30

尚未招募

1 期

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic CancerPancreatic Cancer

NCT06866977Xiangya Hospital of Central South University10